Transdermal Skin Patches Global Market Report 2025
상품코드:1815636
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
경피흡수형 피부 패치 시장 규모는 향후 몇 년 동안 안정적인 성장이 예상됩니다. 2029년에는 CAGR 4.7%로 91억 8,000만 달러에 달할 전망입니다. 예측 기간의 성장은 금연 증가, 고령화 인구의 급증, 의료비 지출 증가, 심혈관 질환 증가에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 연구 기술 발전, 당뇨병 경피 패치 발전, 활발한 R&D 활동, 제품 혁신, 공동 연구 및 파트너십, 웨어러블 피부 패치, 백신 접종용 마이크로니들 패치 발전, 새로운 이온 박리 패치 등이 있습니다.
향후 5년간 4.7%의 성장률 전망은 지난번 예측보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 제한 조치가 발동되면 독일과 스위스에서 생산되는 펜타닐 매트릭스 패치와 경피흡수형 제제의 비용이 상승하고, 만성 통증 치료의 선택권을 훼손함으로써 미국의 통증 관리 센터가 어려움을 겪을 수 있습니다. 또한, 상호 관세와 무역 긴장의 고조와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
심혈관 질환 유병률 증가는 향후 경피흡수형 피부 패치 시장의 성장을 견인할 것으로 예측됩니다. 심혈관 질환은 심장과 혈관에 영향을 미치고 동맥에 지방이 축적되어(죽상동맥경화증) 혈전 위험이 높아지는 경우가 많습니다. 경피흡수형 피부 패치는 심장에 혈액을 공급하는 혈관이 좁아진 관상동맥질환 환자의 협심증(가슴 통증)을 예방하기 위해 사용됩니다. 또한, 심부전 치료에 있어서는 생체 이용률을 높입니다. 예를 들어, 2022년 8월 미국 비영리 의학단체인 미국심장병학회의 보고서에 따르면 2025년부터 2060년까지 미국의 4대 심혈관 질환 위험요인이 모두 증가할 것으로 예측했습니다. 가장 큰 폭 증가가 예상되는 질환은 당뇨병으로 39.3% 증가한 5,500만 명, 다음으로 이상지질혈증(27.6% 증가한 1억 2,600만 명), 고혈압(25.1% 증가한 1억 6,200만 명), 비만(18.3% 증가한 1억 2,600만 명)이 뒤를 이었습니다. 조사 결과, 심혈관질환 발병률이 가장 크게 증가할 것으로 예상되는 질환은 허혈성 심장질환(30.7% 증가, 2,900만 명), 심장마비(16.9% 증가, 1,600만 명), 뇌졸중(33.8% 증가, 1,500만 명), 심부전(33.4% 증가, 1,300만 명)인 것으로 나타났습니다. 증가했습니다. 그 결과, 심혈관 질환의 유병률 증가가 경피흡수성 피부 패치 시장의 확대를 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나19와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 경피흡수형 피부 패치 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 경피흡수형 피부 패치 시장 : 성장률 분석
세계의 경피흡수형 피부 패치 시장 실적 : 규모와 성장, 2019-2024
세계의 경피흡수형 피부 패치 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 경피흡수형 피부 패치 : 총잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 경피흡수형 피부 패치 시장 : 제품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
매트릭스
접착제 내 약물
저장소
증기
세계의 경피흡수형 피부 패치 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
펜타닐 경피 패치
니코틴 경피 패치
부프레노르핀 경피패치
클로니딘 경피 패치
옥시부티닌 경피 패치
기타 유형
세계의 경피흡수형 피부 패치 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
통증 완화
니코틴 금단
호르몬 대체요법
신경계 질환
심혈관 질환
기타 유통 채널
세계의 경피흡수형 피부 패치 시장 : 매트릭스(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
약물 매트릭스
모놀리식 매트릭스
적층 매트릭스
세계의 경피흡수형 피부 패치 시장 : 접착제 내 약물(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
단층 약물 함유 접착제
다층 약물 함유 접착제
세계의 경피흡수형 피부 패치 시장 : 저장소(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
막 제어형 저장소
압력 감지형 저장소
겔 저장소
세계의 경피흡수형 피부 패치 시장 : 증기(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
경피 증기 패치
자기 활성화 증기 패치
증기 디스펜싱 시스템
제7장 지역별/국가별 분석
세계의 경피흡수형 피부 패치 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 경피흡수형 피부 패치 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
경피흡수형 피부 패치 시장 : 경쟁 구도
경피흡수형 피부 패치 시장 : 기업 개요
Novartis : 개요, 제품 및 서비스, 전략 및 재무 분석
Hisamitsu Pharmaceutical Co., Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
Henan Lingrui Pharmaceutical : 개요, 제품 및 서비스, 전략 및 재무 분석
Teva Pharmaceuticals : 개요, 제품 및 서비스, 전략 및 재무 분석
Luye Pharma Group Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Purdue Pharma L.P.
Nitto Denko Corporation
AdhexPharma
Noven Pharmaceuticals
Teikoku Pharma
Mylan Pharmaceuticals Inc
3M Company
Acrux Ltd
Access Pharmaceuticals Inc
Rusan Pharma
Glenmark Pharmaceuticals
Cipla Ltd
Mundipharma
Dr Reddy's Laboratories
Chattem
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
경피흡수형 피부 패치 시장(2029년) : 새로운 기회를 제공하는 국가
경피흡수형 피부 패치 시장(2029년) : 새로운 기회를 제공하는 부문
경피흡수형 피부 패치 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Transdermal skin patches represent a drug delivery method wherein a predetermined dose of medication is administered through an adhesive patch, absorbing into the bloodstream via the skin. These patches offer a precise and predetermined dosage of medication, facilitating absorption through the skin into the bloodstream.
The primary categories within the transdermal skin patches market include fentanyl transdermal patches, nicotine transdermal patches, buprenorphine transdermal patches, clonidine transdermal patches, oxybutynin transdermal patches, and others. Nicotine transdermal skin patches are designed to aid individuals in quitting smoking by providing a controlled source of nicotine through the skin, helping alleviate withdrawal symptoms associated with smoking cessation. Various products in this market utilize matrix, drugs in the adhesive, reservoir, and vapor technologies, catering to applications such as pain relief, nicotine cessation, hormone replacement therapy, as well as addressing neurological and cardiovascular disorders, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The transdermal skin patches market research report is one of a series of new reports from The Business Research Company that provides transdermal skin patches market statistics, including transdermal skin patches industry global market size, regional shares, competitors with a transdermal skin patches market share, detailed transdermal skin patches market segments, market trends and opportunities, and any further data you may need to thrive in the transdermal skin patches industry. This transdermal skin patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The transdermal skin patches market size has grown steadily in recent years. It will grow from $7.46 billion in 2024 to $7.65 billion in 2025 at a compound annual growth rate (CAGR) of 2.5%. The growth in the historic period can be attributed to increasing incidence of cardiovascular diseases, strong economic growth in emerging markets, the increase in pharmaceutical r&d expenditure and increased healthcare expenditure.
The transdermal skin patches market size is expected to see steady growth in the next few years. It will grow to $9.18 billion in 2029 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to the increase in smoking cessation, the rapid growth in the aging population, the increasing healthcare expenditure and the increase in cardiovascular diseases. Major trends in the forecast period include technological advancement in transdermal skin patches, advancements in diabetes transdermal patches, robust research and development activities, product innovation, collaborations and partnerships, wearable skin patches, advancements in microneedle patches for vaccination and new iontophoresis patches.
The forecast of 4.7% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of trade restrictions may challenge U.S. pain management centers by increasing costs of fentanyl matrix patches and transdermal delivery systems manufactured in Germany and Switzerland, compromising chronic pain treatment options. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of cardiovascular disease is anticipated to drive the growth of the transdermal skin patches market in the future. Cardiovascular diseases affect the heart and blood vessels and are often associated with the buildup of fatty deposits in the arteries (atherosclerosis) and an increased risk of blood clots. Transdermal skin patches are utilized to prevent angina (chest pain) in individuals with coronary artery disease, characterized by narrowed blood vessels supplying the heart. They also enhance bioavailability in the treatment of heart failure. For instance, in August 2022, a report from the American College of Cardiology, a U.S.-based non-profit medical association, projected that all four cardiovascular risk factors in the United States would rise between 2025 and 2060. The most significant increase is expected in diabetes, with a 39.3% rise to 55 million individuals, followed by dyslipidemia (up 27.6% to 126 million), hypertension (up 25.1% to 162 million), and obesity (up 18.3% to 126 million). The research also indicated that the most substantial projected increases in cardiovascular disease rates would be for stroke (up 33.8% to 15 million) and heart failure (up 33.4% to 13 million), along with ischemic heart disease (up 30.7% to 29 million) and heart attack (up 16.9% to 16 million). Consequently, the growing prevalence of cardiovascular disease is propelling the expansion of the transdermal skin patches market.
The growth of the transdermal skin patches market is significantly influenced by advancements in modern technologies. These technological advances are expanding the range of drugs that can be delivered transdermally, encompassing small molecule hydrophobic drugs, hydrophilic drugs, and macromolecules. The enhanced technological capabilities contribute to increased efficiency and the broader adoption of transdermal drug delivery systems (TDDS), consequently elevating the popularity and demand for TDDS. For instance, in September 2022, Corium, a biopharmaceutical company based in the United States, introduced Adlarity, a transdermal patch designed for Alzheimer's treatment. Utilizing the unique Corplex technology, Adlarity provides controlled and sustained release of donepezil, benefiting individuals with Alzheimer's-related dementia across various severity levels.
Leading companies in the transdermal skin patches market are intensifying their focus on introducing innovative products and securing approvals to establish a competitive advantage. Innovative products refer to novel or improved solutions addressing existing problems or needs, such as drugs or medical devices. In March 2022, Noven Pharmaceuticals Inc., a U.S.-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for XELSTRY (dextroamphetamine) transdermal system. This marked the first and only approved amphetamine patch for treating ADHD (Attention-Deficit or Hyperactivity Disorder). XELSTRYM, intended for use two hours before the required effect, provides sustained release for nine hours, allowing for personalized dosages based on clinical response and tolerability.
Major companies in the transdermal skin patches market are increasingly pursuing acquisitions and collaborations to strengthen and broaden their presence for market growth. These strategic mergers and acquisitions, along with collaborations, enable companies to leverage new technologies, helping them gain a competitive edge. For example, in August 2022, LTS LOHMANN Therapie-Systeme AG, a Germany-based firm specializing in medical adhesive technologies, acquired Tapemark Inc. for an undisclosed amount. This acquisition allows Tapemark's St. Paul facility to integrate into LTS's global operations network, complementing LTS's existing facilities in Germany and West Caldwell, NJ, in the U.S. Tapemark Inc. is a U.S.-based manufacturer of transdermal skin patches used for delivering medications through the skin.
In January 2022, Cumberland Pharmaceuticals Inc., a U.S.-based specialty pharmaceutical company, acquired Sancuso, a granisetron transdermal patch, from Kyowa Kirin for $13.5 million. This transaction granted Cumberland the U.S. rights to SANCUSO, enabling full control over its commercial aspects, including marketing, distribution, manufacturing, and medical support. SANCUSO, developed by Kyowa Kirin, is a transdermal patch delivering granisetron, a serotonin-3 (5-HT3) receptor antagonist, to prevent chemotherapy-induced nausea and vomiting (CINV).
Major companies operating in the transdermal skin patches market include Novartis, Hisamitsu Pharmaceutical Co., Inc, Henan Lingrui Pharmaceutical, Teva Pharmaceuticals, Luye Pharma Group Ltd, Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc, 3M Company, Acrux Ltd, Access Pharmaceuticals Inc, Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd, Mundipharma, Dr Reddy's Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Europlaz Technologies Ltd, Zentiva, Medical-Lomza Sp. z o.o., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Endo Pharmaceuticals Inc.
North America was the largest region in the global transdermal skin patches market in 2024. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the transdermal skin patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The transdermal skin patches market consists of sales of single-layer drug-in-adhesive, multi-layer drug-in-adhesive, and vapor patch. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Transdermal Skin Patches Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on transdermal skin patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for transdermal skin patches ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transdermal skin patches market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Matrix, Drug In Adhesive, Reservoir, Vapor
2) By Type: Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Estradiol Transdermal Patch, Clonidine Transdermal Patch, Testosterone Transdermal Patch, Other Types
3) By Distribution Channel: Pain Relief, Nicotine Cessation,Hormone Replacement Therapy, Neurological Disorders, Cardiovascular Disorders, Other Applications
Subsegments:
1) By Matrix: Drug-in-matrix Patches; Polymer Matrix Patches
2) By Drug In Adhesive: Adhesive Matrix Patches With The Drug Incorporated In The Adhesive Layer
3) By Reservoir: Drug Reservoir Patches With A Separate Compartment For The Drug; Multi-layer Reservoir Patches
4) By Vapor: Vapor Patches That Release Active Ingredients In Vapor Form; Transdermal Patches Utilizing Vaporization Technology
3. Transdermal Skin Patches Market Trends And Strategies
4. Transdermal Skin Patches Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Transdermal Skin Patches Growth Analysis And Strategic Analysis Framework
5.1. Global Transdermal Skin Patches PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Transdermal Skin Patches Market Growth Rate Analysis
5.4. Global Transdermal Skin Patches Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Transdermal Skin Patches Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Transdermal Skin Patches Total Addressable Market (TAM)
6. Transdermal Skin Patches Market Segmentation
6.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Matrix
Drug In Adhesive
Reservoir
Vapor
6.2. Global Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Other Types
6.3. Global Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pain Relief
Nicotine Cessation
Hormone Replacement Therapy
Neurological Disorders
Cardiovascular Disorders
Other Distribution Channels
6.4. Global Transdermal Skin Patches Market, Sub-Segmentation Of Matrix, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-In-Matrix
Monolithic Matrix
Laminated Matrix
6.5. Global Transdermal Skin Patches Market, Sub-Segmentation Of Drug In Adhesive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Layer Drug In Adhesive
Multi-Layer Drug In Adhesive
6.6. Global Transdermal Skin Patches Market, Sub-Segmentation Of Reservoir, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Membrane-Controlled Reservoir
Pressure-Sensitive Reservoir
Gel Reservoir
6.7. Global Transdermal Skin Patches Market, Sub-Segmentation Of Vapor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Transdermal Vapor Patches
Self-Activated Vapor Patches
Vapor Dispensing Systems
7. Transdermal Skin Patches Market Regional And Country Analysis
7.1. Global Transdermal Skin Patches Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Transdermal Skin Patches Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Transdermal Skin Patches Market
9.1. China Transdermal Skin Patches Market Overview
9.2. China Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Transdermal Skin Patches Market
10.1. India Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Transdermal Skin Patches Market
11.1. Japan Transdermal Skin Patches Market Overview
11.2. Japan Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Transdermal Skin Patches Market
12.1. Australia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Transdermal Skin Patches Market
13.1. Indonesia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Transdermal Skin Patches Market
14.1. South Korea Transdermal Skin Patches Market Overview
14.2. South Korea Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Transdermal Skin Patches Market
15.1. Western Europe Transdermal Skin Patches Market Overview
15.2. Western Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Transdermal Skin Patches Market
16.1. UK Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Transdermal Skin Patches Market
17.1. Germany Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Transdermal Skin Patches Market
18.1. France Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Transdermal Skin Patches Market
19.1. Italy Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Transdermal Skin Patches Market
20.1. Spain Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Transdermal Skin Patches Market
21.1. Eastern Europe Transdermal Skin Patches Market Overview
21.2. Eastern Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Transdermal Skin Patches Market
22.1. Russia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Transdermal Skin Patches Market
23.1. North America Transdermal Skin Patches Market Overview
23.2. North America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Transdermal Skin Patches Market
24.1. USA Transdermal Skin Patches Market Overview
24.2. USA Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Transdermal Skin Patches Market
26.1. South America Transdermal Skin Patches Market Overview
26.2. South America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Transdermal Skin Patches Market
27.1. Brazil Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Transdermal Skin Patches Market
28.1. Middle East Transdermal Skin Patches Market Overview
28.2. Middle East Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Transdermal Skin Patches Market
29.1. Africa Transdermal Skin Patches Market Overview
29.2. Africa Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Transdermal Skin Patches Market Competitive Landscape And Company Profiles
